Monoclonal Antibody-Based Therapeutics for Botulism

Information

• Research Project
• 8151550

• ApplicationId

  8151550

• Core Project Number

  272200800028C-2-0-1

• Full Project Number

  272200800028C-2-0-1

• Serial Number

  0

• FOA Number

• Sub Project Id

• Project Start Date

  9/15/2008 - 17 years ago

• Project End Date

  9/14/2014 - 11 years ago

• Program Officer Name

• Budget Start Date

  -

• Budget End Date

  -

• Fiscal Year

  2010

• Support Year

• Suffix

• Award Notice Date

  -

Organizations

• XOMA CORPORATION

This contract supports the development and preclinical evaluation of monoclonal antibody-based treatments for botulism caused by botulinum neurotoxin serotypes B and E. It includes development of master cell banks, manufacturing process development, formulation and preclinical safety testing. Initially, serotype specific products will be developed. The final objective is to develop a single product that is effective against serotypes A, B and E.

IC Name

• Activity

  N01

• Administering IC

  AI

• Application Type

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  11731128

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

  855

• Ed Inst. Type

• Funding ICs

  NIAID:11731128\

• Funding Mechanism

  Contracts, Extramural

• Study Section

• Study Section Name

• Organization Name

  XOMA CORPORATION

• Organization Department

• Organization DUNS

  152110149

• Organization City

  BERKELEY

• Organization State

  CA

• Organization Country

  UNITED STATES

• Organization Zip Code

  947102743

• Organization District

  UNITED STATES